Russell Szmulewitz to Early Termination of Clinical Trials
This is a "connection" page, showing publications Russell Szmulewitz has written about Early Termination of Clinical Trials.
Connection Strength
0.048
-
A trial postmortem: challenges in conducting a randomized, double-blind, phase 2 study in men with castration-resistant prostate cancer. Eur Urol. 2012 Nov; 62(5):864-6.
Score: 0.025
-
A randomized, phase II study of pazopanib in castrate-sensitive prostate cancer: a University of Chicago Phase II Consortium/Department of Defense Prostate Cancer Clinical Trials Consortium study. Prostate Cancer Prostatic Dis. 2012 Mar; 15(1):87-92.
Score: 0.023